PALISADE BIO, INC. (PALI) has 6 SEC Form 4 insider filings on record in the last 90 days. That includes 3 insider purchases totalling $250K. Most recent filing: Aug. 21, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 21, 2026 filed Aug. 19, 2026 | Finley John David CEO, CFO | $0 | 176,800 | 0% | No | |
|
|
||||||
| July 10, 2026 filed July 8, 2026 | Baltera Robert Jr. Director | +$88,698 | 45,000 | +11% | No | |
|
|
||||||
| July 8, 2026 filed July 6, 2026 | Baltera Robert Jr. Director | +$102,084 | 50,000 | +14% | No | |
|
|
||||||
| July 8, 2026 filed July 6, 2026 | Jones Mitchell Lawrence Chief Medical Officer | — | +79,287 | +539% | No | |
|
|
||||||
| July 8, 2026 filed July 6, 2026 | Finley John David CEO, CFO | — | +188,502 | — | No | |
|
|
||||||
Showing the 5 most recent of 6 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free